Regulation of gene expression by miRNA-455-3p, upregulated in the conjunctival epithelium of patients with Stevens–Johnson syndrome in the chronic stage View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2020-10-14

AUTHORS

Mayumi Ueta, Hiromi Nishigaki, Chie Sotozono, Norihiko Yokoi, Katsura Mizushima, Yuji Naito, Shigeru Kinoshita

ABSTRACT

To investigate the role of miRNA in the pathogenesis underlying ocular surface complications in patients with Stevens–Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) in the chronic stage. Using oligonucleotide microarrays, we performed comprehensive miRNA analysis of the conjunctival epithelium of SJS/TEN patients with severe ocular complications (SOC) in the chronic stage (n = 3). Conjunctival epithelium of patients with conjunctival chalasis (n = 3) served as the control. We confirmed the down- and up-regulation of miRNA of interest by quantitative real-time polymerase chain reaction (RT-PCR) assays using the conjunctival epithelium from 6 SJS/TEN with SOC patients and 7 controls. We focused on miRNA-455-3p, which is significantly upregulated in the conjunctival epithelium of the SJS/TEN patients, and investigated its function by inhibiting miR-455-3p in primary human conjunctival epithelial cells (PHCjEs). Comprehensive miRNA expression analysis showed that the expression of 5 kinds of miRNA was up-regulated more than fivefold, and that the expression of another 5 kinds of miRNA was down-regulated by less than one-fifth. There was a significant difference between the SJS/TEN patients and the controls [analysis of variance (ANOVA) p < 0.05]. Quantitative miRNA PCR assay showed that hsa-miR-31* and hsa-miR-455-3p were significantly up-regulated in the conjunctival epithelium of the SJS/TEN patients. Comprehensive gene expression analysis of PHCjEs transfected with the hsa-miR-455-3p inhibitor and quantitative RT PCR assay showed that ANKRD1, CXCL8, CXCL2, GEM, PTGS2, RNASE8, IL6, and CXCL1 were down-regulated by the hsa-miR-455-3p inhibitor. Quantitative RT-PCR, focused on the genes that tended to be up-regulated in SJS/TEN with SOC, revealed that the expression of IL1A, KPRP, IL36G, PPP1R3C, and ADM was significantly down-regulated in PHCjEs transfected with the hsa-miR-455-3p inhibitor. Our results suggest that miRNA-455-3p could regulate many genes including innate immune related genes in human conjunctival epithelium, and that its up-regulation contributes to the pathogenesis on the ocular surface in SJS/TEN patients with the SOC in the chronic stage. Our findings may lead to the development of new treatments using the miRNA-455-3p inhibitor. More... »

PAGES

17239

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/s41598-020-74211-9

DOI

http://dx.doi.org/10.1038/s41598-020-74211-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1131657968

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/33057072


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0604", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Genetics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemokine CXCL2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Conjunctiva", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Epithelium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interleukin-8", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "MicroRNAs", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Muscle Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nuclear Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Repressor Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stevens-Johnson Syndrome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajiicho, Hirokoji, Kawaramachi, Kamigyoku, 602-0841, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272458.e", 
          "name": [
            "Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajiicho, Hirokoji, Kawaramachi, Kamigyoku, 602-0841, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ueta", 
        "givenName": "Mayumi", 
        "id": "sg:person.0741226323.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741226323.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajiicho, Hirokoji, Kawaramachi, Kamigyoku, 602-0841, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272458.e", 
          "name": [
            "Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajiicho, Hirokoji, Kawaramachi, Kamigyoku, 602-0841, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nishigaki", 
        "givenName": "Hiromi", 
        "id": "sg:person.016704171427.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016704171427.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272458.e", 
          "name": [
            "Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sotozono", 
        "givenName": "Chie", 
        "id": "sg:person.0624777723.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624777723.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272458.e", 
          "name": [
            "Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yokoi", 
        "givenName": "Norihiko", 
        "id": "sg:person.01333600101.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333600101.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272458.e", 
          "name": [
            "Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mizushima", 
        "givenName": "Katsura", 
        "id": "sg:person.01054442606.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01054442606.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272458.e", 
          "name": [
            "Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Naito", 
        "givenName": "Yuji", 
        "id": "sg:person.01277631244.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277631244.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajiicho, Hirokoji, Kawaramachi, Kamigyoku, 602-0841, Kyoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.272458.e", 
          "name": [
            "Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajiicho, Hirokoji, Kawaramachi, Kamigyoku, 602-0841, Kyoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kinoshita", 
        "givenName": "Shigeru", 
        "id": "sg:person.01016754101.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016754101.20"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/hgv.2015.23", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007742237", 
          "https://doi.org/10.1038/hgv.2015.23"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/srep04862", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032179384", 
          "https://doi.org/10.1038/srep04862"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10735-012-9459-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048913492", 
          "https://doi.org/10.1007/s10735-012-9459-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12943-017-0669-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1086119173", 
          "https://doi.org/10.1186/s12943-017-0669-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s12276-019-0322-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1121475523", 
          "https://doi.org/10.1038/s12276-019-0322-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13287-020-1550-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1124277847", 
          "https://doi.org/10.1186/s13287-020-1550-0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2020-10-14", 
    "datePublishedReg": "2020-10-14", 
    "description": "To investigate the role of miRNA in the pathogenesis underlying ocular surface complications in patients with Stevens\u2013Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) in the chronic stage. Using oligonucleotide microarrays, we performed comprehensive miRNA analysis of the conjunctival epithelium of SJS/TEN patients with severe ocular complications (SOC) in the chronic stage (n\u2009=\u20093). Conjunctival epithelium of patients with conjunctival chalasis (n\u2009=\u20093) served as the control. We confirmed the down- and up-regulation of miRNA of interest by quantitative real-time polymerase chain reaction (RT-PCR) assays using the conjunctival epithelium from 6 SJS/TEN with SOC patients and 7 controls. We focused on miRNA-455-3p, which is significantly upregulated in the conjunctival epithelium of the SJS/TEN patients, and investigated its function by inhibiting miR-455-3p in primary human conjunctival epithelial cells (PHCjEs). Comprehensive miRNA expression analysis showed that the expression of 5 kinds of miRNA was up-regulated more than fivefold, and that the expression of another 5 kinds of miRNA was down-regulated by less than one-fifth. There was a significant difference between the SJS/TEN patients and the controls [analysis of variance (ANOVA) p\u2009<\u20090.05]. Quantitative miRNA PCR assay showed that hsa-miR-31* and hsa-miR-455-3p were significantly up-regulated in the conjunctival epithelium of the SJS/TEN patients. Comprehensive gene expression analysis of PHCjEs transfected with the hsa-miR-455-3p inhibitor and quantitative RT PCR assay showed that ANKRD1, CXCL8, CXCL2, GEM, PTGS2, RNASE8, IL6, and CXCL1 were down-regulated by the hsa-miR-455-3p inhibitor. Quantitative RT-PCR, focused on the genes that tended to be up-regulated in SJS/TEN with SOC, revealed that the expression of IL1A, KPRP, IL36G, PPP1R3C, and ADM was significantly down-regulated in PHCjEs transfected with the hsa-miR-455-3p inhibitor. Our results suggest that miRNA-455-3p could regulate many genes including innate immune related genes in human conjunctival epithelium, and that its up-regulation contributes to the pathogenesis on the ocular surface in SJS/TEN patients with the SOC in the chronic stage. Our findings may lead to the development of new treatments using the miRNA-455-3p inhibitor.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/s41598-020-74211-9", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.8428869", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.7702483", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1045337", 
        "issn": [
          "2045-2322"
        ], 
        "name": "Scientific Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "10"
      }
    ], 
    "keywords": [
      "SJS/TEN patients", 
      "severe ocular complications", 
      "Stevens-Johnson syndrome", 
      "SJS/TEN", 
      "TEN patients", 
      "chronic stage", 
      "conjunctival epithelium", 
      "quantitative RT-PCR", 
      "comprehensive miRNA expression analysis", 
      "primary human conjunctival epithelial cells", 
      "ocular surface complications", 
      "expression of Il1a", 
      "RT-PCR", 
      "real-time polymerase chain reaction", 
      "comprehensive miRNA analysis", 
      "quantitative real-time polymerase chain reaction", 
      "human conjunctival epithelial cells", 
      "conjunctival epithelial cells", 
      "human conjunctival epithelium", 
      "IL36G", 
      "epidermal necrolysis", 
      "ocular complications", 
      "SOC patients", 
      "surface complications", 
      "polymerase chain reaction", 
      "ocular surface", 
      "patients", 
      "comprehensive gene expression analysis", 
      "new treatments", 
      "conjunctival chalasis", 
      "miRNA expression analysis", 
      "kinds of miRNA", 
      "epithelium", 
      "role of miRNA", 
      "epithelial cells", 
      "chain reaction", 
      "complications", 
      "significant differences", 
      "regulation of miRNA", 
      "syndrome", 
      "pathogenesis", 
      "inhibitors", 
      "expression analysis", 
      "gene expression analysis", 
      "one-fifth", 
      "expression", 
      "gene expression", 
      "oligonucleotide microarrays", 
      "PCR", 
      "miRNA", 
      "necrolysis", 
      "CXCL1", 
      "CXCL2", 
      "miRNA analysis", 
      "CXCL8", 
      "IL6", 
      "IL1A", 
      "control", 
      "PTGS2", 
      "genes", 
      "treatment", 
      "regulation", 
      "ANKRD1", 
      "stage", 
      "KPRP", 
      "ADM", 
      "cells", 
      "PPP1R3C", 
      "microarray", 
      "findings", 
      "differences", 
      "analysis", 
      "role", 
      "function", 
      "development", 
      "results", 
      "reaction", 
      "down", 
      "GEM", 
      "interest", 
      "kind", 
      "surface", 
      "tens"
    ], 
    "name": "Regulation of gene expression by miRNA-455-3p, upregulated in the conjunctival epithelium of patients with Stevens\u2013Johnson syndrome in the chronic stage", 
    "pagination": "17239", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1131657968"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/s41598-020-74211-9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "33057072"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/s41598-020-74211-9", 
      "https://app.dimensions.ai/details/publication/pub.1131657968"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T17:10", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_859.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/s41598-020-74211-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41598-020-74211-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41598-020-74211-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41598-020-74211-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41598-020-74211-9'


 

This table displays all metadata directly associated to this object as RDF triples.

265 TRIPLES      21 PREDICATES      126 URIs      112 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/s41598-020-74211-9 schema:about N091eb18a5d97408a97db3ad2e233bf01
2 N189772f9a3f9458991806e668ea18526
3 N1c9021919a524994a0e09f6f5acd3e2f
4 N23e3db3a736d4663ad6840494234d2dc
5 N268c6c5a7319406c9977947fc8bafb7b
6 N66e65a09c5774c6f8d1b33cd5b2a663f
7 Na66bcc09e7dd463991c7079078d15940
8 Nc27cc900df274e069f56ad548b0b8e05
9 Nc95e52a604c148a99d0545d3db4d2906
10 Nf2c0dd80ce0a4a3dbf84feff06a744d2
11 Nf3219c504a0448509ffac843c04a9468
12 Nf5ef309fcc48427d85fe458d41b76d88
13 anzsrc-for:06
14 anzsrc-for:0604
15 schema:author Nce8dab1b7350491da45fee7849bce9ae
16 schema:citation sg:pub.10.1007/s10735-012-9459-2
17 sg:pub.10.1038/hgv.2015.23
18 sg:pub.10.1038/s12276-019-0322-3
19 sg:pub.10.1038/srep04862
20 sg:pub.10.1186/s12943-017-0669-9
21 sg:pub.10.1186/s13287-020-1550-0
22 schema:datePublished 2020-10-14
23 schema:datePublishedReg 2020-10-14
24 schema:description To investigate the role of miRNA in the pathogenesis underlying ocular surface complications in patients with Stevens–Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) in the chronic stage. Using oligonucleotide microarrays, we performed comprehensive miRNA analysis of the conjunctival epithelium of SJS/TEN patients with severe ocular complications (SOC) in the chronic stage (n = 3). Conjunctival epithelium of patients with conjunctival chalasis (n = 3) served as the control. We confirmed the down- and up-regulation of miRNA of interest by quantitative real-time polymerase chain reaction (RT-PCR) assays using the conjunctival epithelium from 6 SJS/TEN with SOC patients and 7 controls. We focused on miRNA-455-3p, which is significantly upregulated in the conjunctival epithelium of the SJS/TEN patients, and investigated its function by inhibiting miR-455-3p in primary human conjunctival epithelial cells (PHCjEs). Comprehensive miRNA expression analysis showed that the expression of 5 kinds of miRNA was up-regulated more than fivefold, and that the expression of another 5 kinds of miRNA was down-regulated by less than one-fifth. There was a significant difference between the SJS/TEN patients and the controls [analysis of variance (ANOVA) p < 0.05]. Quantitative miRNA PCR assay showed that hsa-miR-31* and hsa-miR-455-3p were significantly up-regulated in the conjunctival epithelium of the SJS/TEN patients. Comprehensive gene expression analysis of PHCjEs transfected with the hsa-miR-455-3p inhibitor and quantitative RT PCR assay showed that ANKRD1, CXCL8, CXCL2, GEM, PTGS2, RNASE8, IL6, and CXCL1 were down-regulated by the hsa-miR-455-3p inhibitor. Quantitative RT-PCR, focused on the genes that tended to be up-regulated in SJS/TEN with SOC, revealed that the expression of IL1A, KPRP, IL36G, PPP1R3C, and ADM was significantly down-regulated in PHCjEs transfected with the hsa-miR-455-3p inhibitor. Our results suggest that miRNA-455-3p could regulate many genes including innate immune related genes in human conjunctival epithelium, and that its up-regulation contributes to the pathogenesis on the ocular surface in SJS/TEN patients with the SOC in the chronic stage. Our findings may lead to the development of new treatments using the miRNA-455-3p inhibitor.
25 schema:genre article
26 schema:isAccessibleForFree true
27 schema:isPartOf N4475938bdb6843e0b61f89332a280399
28 N49687c1fe3f145f2a844c5d54e6b89ec
29 sg:journal.1045337
30 schema:keywords ADM
31 ANKRD1
32 CXCL1
33 CXCL2
34 CXCL8
35 GEM
36 IL1A
37 IL36G
38 IL6
39 KPRP
40 PCR
41 PPP1R3C
42 PTGS2
43 RT-PCR
44 SJS/TEN
45 SJS/TEN patients
46 SOC patients
47 Stevens-Johnson syndrome
48 TEN patients
49 analysis
50 cells
51 chain reaction
52 chronic stage
53 complications
54 comprehensive gene expression analysis
55 comprehensive miRNA analysis
56 comprehensive miRNA expression analysis
57 conjunctival chalasis
58 conjunctival epithelial cells
59 conjunctival epithelium
60 control
61 development
62 differences
63 down
64 epidermal necrolysis
65 epithelial cells
66 epithelium
67 expression
68 expression analysis
69 expression of Il1a
70 findings
71 function
72 gene expression
73 gene expression analysis
74 genes
75 human conjunctival epithelial cells
76 human conjunctival epithelium
77 inhibitors
78 interest
79 kind
80 kinds of miRNA
81 miRNA
82 miRNA analysis
83 miRNA expression analysis
84 microarray
85 necrolysis
86 new treatments
87 ocular complications
88 ocular surface
89 ocular surface complications
90 oligonucleotide microarrays
91 one-fifth
92 pathogenesis
93 patients
94 polymerase chain reaction
95 primary human conjunctival epithelial cells
96 quantitative RT-PCR
97 quantitative real-time polymerase chain reaction
98 reaction
99 real-time polymerase chain reaction
100 regulation
101 regulation of miRNA
102 results
103 role
104 role of miRNA
105 severe ocular complications
106 significant differences
107 stage
108 surface
109 surface complications
110 syndrome
111 tens
112 treatment
113 schema:name Regulation of gene expression by miRNA-455-3p, upregulated in the conjunctival epithelium of patients with Stevens–Johnson syndrome in the chronic stage
114 schema:pagination 17239
115 schema:productId N0f079c2e7bc94fb4ac5d4fec0d00d383
116 N1f7127c3f7964ebe9cd7e8dcd3c8dc4e
117 N6b00263480eb472ebe34ed2a5fbe37e1
118 schema:sameAs https://app.dimensions.ai/details/publication/pub.1131657968
119 https://doi.org/10.1038/s41598-020-74211-9
120 schema:sdDatePublished 2022-08-04T17:10
121 schema:sdLicense https://scigraph.springernature.com/explorer/license/
122 schema:sdPublisher N1a15b33f8d3748ee9cc2b05d05238e76
123 schema:url https://doi.org/10.1038/s41598-020-74211-9
124 sgo:license sg:explorer/license/
125 sgo:sdDataset articles
126 rdf:type schema:ScholarlyArticle
127 N091eb18a5d97408a97db3ad2e233bf01 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Interleukin-8
129 rdf:type schema:DefinedTerm
130 N0f079c2e7bc94fb4ac5d4fec0d00d383 schema:name doi
131 schema:value 10.1038/s41598-020-74211-9
132 rdf:type schema:PropertyValue
133 N189772f9a3f9458991806e668ea18526 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Chemokine CXCL2
135 rdf:type schema:DefinedTerm
136 N1a15b33f8d3748ee9cc2b05d05238e76 schema:name Springer Nature - SN SciGraph project
137 rdf:type schema:Organization
138 N1c9021919a524994a0e09f6f5acd3e2f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Middle Aged
140 rdf:type schema:DefinedTerm
141 N1f7127c3f7964ebe9cd7e8dcd3c8dc4e schema:name dimensions_id
142 schema:value pub.1131657968
143 rdf:type schema:PropertyValue
144 N23e3db3a736d4663ad6840494234d2dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name MicroRNAs
146 rdf:type schema:DefinedTerm
147 N268c6c5a7319406c9977947fc8bafb7b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Humans
149 rdf:type schema:DefinedTerm
150 N2debde84b12249c6b14ca903ba0b6168 rdf:first sg:person.01016754101.20
151 rdf:rest rdf:nil
152 N3fed74c4a86641f7a9545fd77990323f rdf:first sg:person.01054442606.20
153 rdf:rest Nff20d108e9924c259e2210a8838c90e3
154 N4475938bdb6843e0b61f89332a280399 schema:volumeNumber 10
155 rdf:type schema:PublicationVolume
156 N49687c1fe3f145f2a844c5d54e6b89ec schema:issueNumber 1
157 rdf:type schema:PublicationIssue
158 N602dc41c0e224a93b400d636d5aa6627 rdf:first sg:person.0624777723.12
159 rdf:rest Nbaf1c5d949394c228e18a41c80b23526
160 N66e65a09c5774c6f8d1b33cd5b2a663f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Epithelium
162 rdf:type schema:DefinedTerm
163 N6b00263480eb472ebe34ed2a5fbe37e1 schema:name pubmed_id
164 schema:value 33057072
165 rdf:type schema:PropertyValue
166 N8bbf03a820b04773b00e684957406ba3 rdf:first sg:person.016704171427.06
167 rdf:rest N602dc41c0e224a93b400d636d5aa6627
168 Na66bcc09e7dd463991c7079078d15940 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Conjunctiva
170 rdf:type schema:DefinedTerm
171 Nbaf1c5d949394c228e18a41c80b23526 rdf:first sg:person.01333600101.93
172 rdf:rest N3fed74c4a86641f7a9545fd77990323f
173 Nc27cc900df274e069f56ad548b0b8e05 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Stevens-Johnson Syndrome
175 rdf:type schema:DefinedTerm
176 Nc95e52a604c148a99d0545d3db4d2906 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Repressor Proteins
178 rdf:type schema:DefinedTerm
179 Nce8dab1b7350491da45fee7849bce9ae rdf:first sg:person.0741226323.70
180 rdf:rest N8bbf03a820b04773b00e684957406ba3
181 Nf2c0dd80ce0a4a3dbf84feff06a744d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Nuclear Proteins
183 rdf:type schema:DefinedTerm
184 Nf3219c504a0448509ffac843c04a9468 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Adult
186 rdf:type schema:DefinedTerm
187 Nf5ef309fcc48427d85fe458d41b76d88 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Muscle Proteins
189 rdf:type schema:DefinedTerm
190 Nff20d108e9924c259e2210a8838c90e3 rdf:first sg:person.01277631244.48
191 rdf:rest N2debde84b12249c6b14ca903ba0b6168
192 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
193 schema:name Biological Sciences
194 rdf:type schema:DefinedTerm
195 anzsrc-for:0604 schema:inDefinedTermSet anzsrc-for:
196 schema:name Genetics
197 rdf:type schema:DefinedTerm
198 sg:grant.7702483 http://pending.schema.org/fundedItem sg:pub.10.1038/s41598-020-74211-9
199 rdf:type schema:MonetaryGrant
200 sg:grant.8428869 http://pending.schema.org/fundedItem sg:pub.10.1038/s41598-020-74211-9
201 rdf:type schema:MonetaryGrant
202 sg:journal.1045337 schema:issn 2045-2322
203 schema:name Scientific Reports
204 schema:publisher Springer Nature
205 rdf:type schema:Periodical
206 sg:person.01016754101.20 schema:affiliation grid-institutes:grid.272458.e
207 schema:familyName Kinoshita
208 schema:givenName Shigeru
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016754101.20
210 rdf:type schema:Person
211 sg:person.01054442606.20 schema:affiliation grid-institutes:grid.272458.e
212 schema:familyName Mizushima
213 schema:givenName Katsura
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01054442606.20
215 rdf:type schema:Person
216 sg:person.01277631244.48 schema:affiliation grid-institutes:grid.272458.e
217 schema:familyName Naito
218 schema:givenName Yuji
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277631244.48
220 rdf:type schema:Person
221 sg:person.01333600101.93 schema:affiliation grid-institutes:grid.272458.e
222 schema:familyName Yokoi
223 schema:givenName Norihiko
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333600101.93
225 rdf:type schema:Person
226 sg:person.016704171427.06 schema:affiliation grid-institutes:grid.272458.e
227 schema:familyName Nishigaki
228 schema:givenName Hiromi
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016704171427.06
230 rdf:type schema:Person
231 sg:person.0624777723.12 schema:affiliation grid-institutes:grid.272458.e
232 schema:familyName Sotozono
233 schema:givenName Chie
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624777723.12
235 rdf:type schema:Person
236 sg:person.0741226323.70 schema:affiliation grid-institutes:grid.272458.e
237 schema:familyName Ueta
238 schema:givenName Mayumi
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741226323.70
240 rdf:type schema:Person
241 sg:pub.10.1007/s10735-012-9459-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048913492
242 https://doi.org/10.1007/s10735-012-9459-2
243 rdf:type schema:CreativeWork
244 sg:pub.10.1038/hgv.2015.23 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007742237
245 https://doi.org/10.1038/hgv.2015.23
246 rdf:type schema:CreativeWork
247 sg:pub.10.1038/s12276-019-0322-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1121475523
248 https://doi.org/10.1038/s12276-019-0322-3
249 rdf:type schema:CreativeWork
250 sg:pub.10.1038/srep04862 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032179384
251 https://doi.org/10.1038/srep04862
252 rdf:type schema:CreativeWork
253 sg:pub.10.1186/s12943-017-0669-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1086119173
254 https://doi.org/10.1186/s12943-017-0669-9
255 rdf:type schema:CreativeWork
256 sg:pub.10.1186/s13287-020-1550-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1124277847
257 https://doi.org/10.1186/s13287-020-1550-0
258 rdf:type schema:CreativeWork
259 grid-institutes:grid.272458.e schema:alternateName Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajiicho, Hirokoji, Kawaramachi, Kamigyoku, 602-0841, Kyoto, Japan
260 Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan
261 Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan
262 schema:name Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajiicho, Hirokoji, Kawaramachi, Kamigyoku, 602-0841, Kyoto, Japan
263 Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan
264 Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan
265 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...